{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:45:36Z","timestamp":1792165536086,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10370-8","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:40:21Z","timestamp":1735893621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-2720","authenticated-orcid":false,"given":"Zhimin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"12","key":"10370_CR1","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.rmed.2008.06.022","volume":"102","author":"A Defilippi","year":"2008","unstructured":"Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, Cirillo C, Di Pietro P, Rossi GA. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med. 2008;102(12):1762\u20138.","journal-title":"Respir Med"},{"issue":"1","key":"10370_CR2","doi-asserted-by":"publisher","first-page":"21859","DOI":"10.1038\/s41598-022-26565-5","volume":"12","author":"Y Ren","year":"2022","unstructured":"Ren Y, Wang Y, Liang R, Hao B, Wang H, Yuan J, Wang L, Guo Z, Zhang J. Development and validation of a nomogram for predicting Mycoplasma pneumoniae pneumonia in adults. Sci Rep. 2022;12(1):21859.","journal-title":"Sci Rep"},{"issue":"8","key":"10370_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.eimc.2021.10.004","volume":"40","author":"AI \u00c1lvaro Varela","year":"2022","unstructured":"\u00c1lvaro Varela AI, Aguinaga P\u00e9rez A, Navascu\u00e9s Ortega A, Castilla J, Ezpeleta Baquedano C. Clinical characteristics of patients with Mycoplasma pneumoniae infection. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(8):449\u201352.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"11","key":"10370_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/crj.13549","volume":"16","author":"M Sung","year":"2022","unstructured":"Sung M, Roh EJ, Lee ES, Lee JY, Kim HB, Ahn Y, Eun BW, Kim JK, Kim HY, Jung SS, et al. Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia. Clin Respir J. 2022;16(11):756\u201367.","journal-title":"Clin Respir J"},{"issue":"8","key":"10370_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.cmi.2016.05.028","volume":"22","author":"T Khoury","year":"2016","unstructured":"Khoury T, Sviri S, Rmeileh AA, Nubani A, Abutbul A, Hoss S, van Heerden PV, Bayya AE, Hidalgo-Grass C, Moses AE, et al. Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study. Clin Microbiol Infect. 2016;22(8):711\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"10370_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fmicb.2016.00157","volume":"7","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Nguipdop-Djomo P, Zhao H, Stanford E, Spiller OB, Chalker VJ. Mycoplasma pneumoniae epidemiology in England and Wales: a national perspective. Front Microbiol. 2016;7:157.","journal-title":"Front Microbiol"},{"key":"10370_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijid.2019.02.030","volume":"81","author":"S Zhao","year":"2019","unstructured":"Zhao S, Musa SS, Qin J, He D. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018. Int J Infect Dis. 2019;81:251\u20133.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10370_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/pathogens10020119","volume":"10","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Li S, Zhu C, Zhou R, Leung PHM. Mycoplasma pneumoniae infections: pathogenesis and vaccine development. Pathogens. 2021;10(2):119.","journal-title":"Pathogens"},{"key":"10370_CR9","doi-asserted-by":"publisher","first-page":"102589","DOI":"10.1016\/j.eclinm.2024.102589","volume":"71","author":"F Cai","year":"2024","unstructured":"Cai F, Li J, Liang W, Wang L, Ruan J. Effectiveness and safety of tetracyclines and quinolones in people with Mycoplasma pneumonia: a systematic review and network meta-analysis. EClinicalMedicine. 2024;71:102589.","journal-title":"EClinicalMedicine"},{"key":"10370_CR10","doi-asserted-by":"publisher","first-page":"1115009","DOI":"10.3389\/fped.2023.1115009","volume":"11","author":"M Leng","year":"2023","unstructured":"Leng M, Yang J, Zhou J. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Front Pediatr. 2023;11:1115009.","journal-title":"Front Pediatr."},{"issue":"7","key":"10370_CR11","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(7):e2220949\u2013e2220949.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10370_CR12","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li P, Wang W, Zhang X, Pan J, Gong L. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep. 2024;14(1):5632.","journal-title":"Sci Rep"},{"issue":"2","key":"10370_CR13","doi-asserted-by":"publisher","first-page":"1900112","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112","volume":"25","author":"ML Beeton","year":"2020","unstructured":"Beeton ML, Zhang XS, Uldum SA, B\u00e9b\u00e9ar C, Dumke R, Gullsby K, Ieven M, Loens K, Nir-Paz R, Pereyre S, et al. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Euro Surveill. 2020;25(2):1900112.","journal-title":"Euro Surveill"},{"issue":"1","key":"10370_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, Wang Y, Yu X, Li A, Dong M, et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect. 2022;11(1):1508\u201317.","journal-title":"Emerg Microbes Infect"},{"issue":"11","key":"10370_CR15","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/antibiotics12111623","volume":"12","author":"S Shin","year":"2023","unstructured":"Shin S, Koo S, Yang YJ, Lim HJ. Characteristics of the Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide resistance and co-infection trends. Antibiotics (Basel). 2023;12(11):1623.","journal-title":"Antibiotics (Basel)"},{"issue":"19","key":"10370_CR16","doi-asserted-by":"publisher","first-page":"21007461undefin","DOI":"10.2807\/1560-7917.ES.2022.27.19.2100746","volume":"27","author":"PM Meyer Sauteur","year":"2022","unstructured":"Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, Pereyre S, B\u00e9b\u00e9ar C, Ke\u0161e D, Day J, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill. 2022;27(19):21007461undefined.","journal-title":"Euro Surveill"},{"issue":"12","key":"10370_CR17","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2666-5247(22)00190-2","volume":"3","author":"PMM Sauteur","year":"2022","unstructured":"Sauteur PMM, Chalker VJ, Berger C, Nir-Paz R, Beeton ML, Pereyre S, B\u00e9b\u00e9ar C, Wagner N, Andreutti C, Greub G, et al. Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it? Lancet Microbe. 2022;3(12):e897.","journal-title":"Lancet Microbe"},{"issue":"8","key":"10370_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.46234\/ccdcw2024.027","volume":"6","author":"Y Li","year":"2024","unstructured":"Li Y, Yan Y, Huang J, Shi Y, Du H, Xiong C, Chen K, Liu D, Lu X. Respiratory viruses and mycoplasma pneumoniae surveillance among hospitalized children with acute respiratory infections - Wuhan City, Hubei Province, China, September-November 2023. China CDC Wkly. 2024;6(8):139\u201342.","journal-title":"China CDC Wkly"},{"issue":"6","key":"10370_CR19","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1016\/S2666-5247(23)00405-6","volume":"5","author":"H Li","year":"2024","unstructured":"Li H, Li S, Yang H, Chen Z, Zhou Z. Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China. Lancet Microbe. 2024;5(6):e515.","journal-title":"Lancet Microbe"},{"key":"10370_CR20","doi-asserted-by":"publisher","first-page":"1300228","DOI":"10.3389\/fpubh.2023.1300228","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Huang X, Zhang J, Tao Z. Risk factors for hospitalization and pneumonia development of pediatric patients with seasonal influenza during February\u2013April 2023. Front Public Health. 2024;11:1300228.","journal-title":"Front Public Health."},{"issue":"1","key":"10370_CR21","first-page":"13","volume":"6","author":"D Yanjun","year":"2023","unstructured":"Yanjun D, Hao X, Hu E, Zhu B, Gao J, Cheng X, Jing J, Zhao Y, Jia J, Yuan C. Laboratory practice of reference intervals modification for children\u2019s blood cell analysis in China. Adv Hematol Oncol Res. 2023;6(1):13\u201323.","journal-title":"Adv Hematol Oncol Res"},{"issue":"1","key":"10370_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang S, Lu S, Guo Y, Luan W, Liu J, Wang L. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children. BMC Infect Dis. 2024;24(1):449.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10370_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1186\/s12879-024-10070-3","volume":"24","author":"X Song","year":"2024","unstructured":"Song X, Zhou N, Lu S, Gu C, Qiao X. New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis. BMC Infect Dis. 2024;24(1):1166.","journal-title":"BMC Infect Dis"},{"key":"10370_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fmicb.2016.00513","volume":"7","author":"GL Parrott","year":"2016","unstructured":"Parrott GL, Kinjo T, Fujita J. A compendium for Mycoplasma pneumoniae. Front Microbiol. 2016;7:513.","journal-title":"Front Microbiol"},{"issue":"3","key":"10370_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ila2.27","volume":"1","author":"H Sun","year":"2023","unstructured":"Sun H, Xiao L. Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic. iLABMED. 2023;1(3):148\u201357.","journal-title":"iLABMED"},{"issue":"1","key":"10370_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00284-022-03103-0","volume":"80","author":"J Hu","year":"2022","unstructured":"Hu J, Ye Y, Chen X, Xiong L, Xie W, Liu P. Insight into the pathogenic mechanism of Mycoplasma pneumoniae. Curr Microbiol. 2022;80(1):14.","journal-title":"Curr Microbiol"},{"issue":"8","key":"10370_CR27","first-page":"e03615","volume":"12","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Kang H, Dou H, Guo D, Yuan Q, Dong L, Du Z, Zhao W, Xin D. Comparative genomic sequencing to characterize Mycoplasma pneumoniae genome, typing, and drug resistance. Microbiol\u00a0Spectr. 2024;12(8):e03615-03623.","journal-title":"Microbiol\u00a0Spectr"},{"issue":"20","key":"10370_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.21037\/atm-22-4304","volume":"10","author":"YT Lv","year":"2022","unstructured":"Lv YT, Sun XJ, Chen Y, Ruan T, Xu GP, Huang JA. Epidemic characteristics of Mycoplasma pneumoniae infection: a retrospective analysis of a single center in Suzhou from 2014 to 2020. Ann Transl Med. 2022;10(20):1123.","journal-title":"Ann Transl Med"},{"issue":"1","key":"10370_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12866-024-03180-0","volume":"24","author":"M Xu","year":"2024","unstructured":"Xu M, Li Y, Shi Y, Liu H, Tong X, Ma L, Gao J, Du Q, Du H, Liu D, et al. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020\u20132022. BMC Microbiol. 2024;24(1):23.","journal-title":"BMC Microbiol"},{"issue":"9","key":"10370_CR30","doi-asserted-by":"publisher","first-page":"100870","DOI":"10.1016\/S2666-5247(24)00086-7","volume":"5","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li X, Fu Y, Yu Y, Zhou H. Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniaein mainland China. Lancet Microbe. 2024;5(9):100870.","journal-title":"Lancet Microbe"},{"issue":"1","key":"10370_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-023-00793-9","volume":"20","author":"XB Zhang","year":"2024","unstructured":"Zhang XB, He W, Gui YH, Lu Q, Yin Y, Zhang JH, Dong XY, Wang YW, Ye YZ, Xu H, et al. Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen. World J Pediatr. 2024;20(1):5\u201310.","journal-title":"World J Pediatr"},{"issue":"9","key":"10370_CR32","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00484-024-02712-7","volume":"68","author":"K Wagatsuma","year":"2024","unstructured":"Wagatsuma K. Effect of meteorological factors on the incidence of Mycoplasma pneumoniae pneumonia in Japan: a time series analysis. Int J Biometeorol. 2024;68(9):1903\u20137.","journal-title":"Int J Biometeorol"},{"key":"10370_CR33","doi-asserted-by":"publisher","first-page":"1200617","DOI":"10.3389\/fcimb.2023.1200617","volume":"13","author":"MC Yang","year":"2023","unstructured":"Yang MC, Su YT, Chen PH, Tsai CC, Lin TI, Wu JR. Changing patterns of infectious diseases in children during the COVID-19 pandemic. Front Cell Infect Microbiol. 2023;13:1200617.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10370_CR34","doi-asserted-by":"publisher","first-page":"2332680","DOI":"10.1080\/22221751.2024.2332680","volume":"13","author":"AD Urbieta","year":"2024","unstructured":"Urbieta AD, Barbeito Casti\u00f1eiras G, Rivero Calle I, Pardo Seco J, Rodr\u00edguez Tenreiro C, Su\u00e1rez Camacho R, Del Molino P, Bernal ML, Martin\u00f3n Torres F. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain. Emerg Microbes Infect. 2024;13(1):2332680.","journal-title":"Emerg Microbes Infect"},{"issue":"11","key":"10370_CR35","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1017\/S0950268818000778","volume":"146","author":"X Zhang","year":"2018","unstructured":"Zhang X, Chen Z, Gu W, Ji W, Wang Y, Hao C, He Y, Huang L, Wang M, Shao X, et al. Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia. Epidemiol Infect. 2018;146(11):1384\u20138.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10370_CR36","doi-asserted-by":"publisher","first-page":"e29602","DOI":"10.1002\/jmv.29602","volume":"96","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Wang Y, Yi J, Guo L, Wang Q, Zhang G, Xu Y, Zhao Y. Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: a retrospective study. J Med Virol. 2024;96(4):e29602.","journal-title":"J Med Virol"},{"issue":"1","key":"10370_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12879-022-07715-6","volume":"22","author":"L Li","year":"2022","unstructured":"Li L, Ma J, Guo P, Song X, Li M, Yu Z, Yu Z, Cheng P, Sun H, Zhang W. Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children. BMC Infect Dis. 2022;22(1):724.","journal-title":"BMC Infect Dis"},{"key":"10370_CR38","doi-asserted-by":"crossref","unstructured":"Xu Y, Yang C, Sun P, Zeng F, Wang Q, Wu J, Fang C, Zhang C, Wang J, Gu Y, et al. Epidemic features and megagenomic analysis of childhood mycoplasma pneumoniae post Covid-19 pandemic: a 6-year study in Southern China. Emerg Microbes Infect. 2024;13:2353298.","DOI":"10.1080\/22221751.2024.2353298"},{"issue":"10","key":"10370_CR39","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.21037\/jtd.2017.09.75","volume":"9","author":"YD Yin","year":"2017","unstructured":"Yin YD, Wang R, Zhuo C, Wang H, Wang MG, Xie CM, She DY, Yuan X, Wang RT, Cao B, et al. Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study. J Thorac Dis. 2017;9(10):3774\u201381.","journal-title":"J Thorac Dis"},{"issue":"22","key":"10370_CR40","doi-asserted-by":"publisher","first-page":"e20121","DOI":"10.1097\/MD.0000000000020121","volume":"99","author":"JL Qiu","year":"2020","unstructured":"Qiu JL, Huang L, Shao MY, Chai YN, Zhang HJ, Li XF, Sun XX, Zhao QY, Duan F, Zhai WS. Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2020;99(22):e20121.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10370_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12879-020-05356-1","volume":"20","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang J, Chen W, Shen N, Tao Y, Zhao R, Luo L, Li B, Cao Q. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20(1):633.","journal-title":"BMC Infect Dis"},{"key":"10370_CR42","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.2147\/JIR.S387809","volume":"15","author":"Q Xie","year":"2022","unstructured":"Xie Q, Zhang X, Cui W, Pang Y. Construction of a nomogram for identifying refractory Mycoplasma pneumoniae pneumonia among macrolide-unresponsive mycoplasma pneumoniae pneumonia in children. J Inflamm Res. 2022;15:6495\u2013504.","journal-title":"J Inflamm Res"},{"issue":"7","key":"10370_CR43","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00431-024-05519-1","volume":"183","author":"G Ding","year":"2024","unstructured":"Ding G, Zhang X, Vinturache A, van Rossum AMC, Yin Y, Zhang Y. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur J Pediatr. 2024;183(7):3001\u201311.","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10370_CR44","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3201\/eid2310.170106","volume":"23","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M, Ono S, Kato A, Fukuda Y, Saito A, Kondo E, et al. Macrolide-resistant mycoplasma pneumoniae infection, Japan, 2008\u20132015. Emerg Infect Dis. 2017;23(10):1703\u20136.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10370_CR45","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3201\/eid2609.191575","volume":"26","author":"M Morozumi","year":"2020","unstructured":"Morozumi M, Tajima T, Sakuma M, Shouji M, Meguro H, Saito K, Iwata S, Ubukata K. Sequence type changes associated with decreasing macrolide-resistant Mycoplasma pneumoniae, Japan. Emerg Infect Dis. 2020;26(9):2210\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"159","key":"10370_CR46","doi-asserted-by":"publisher","first-page":"200346","DOI":"10.1183\/16000617.0346-2020","volume":"30","author":"I Martin-Loeches","year":"2021","unstructured":"Martin-Loeches I, Torres A. Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm? Eur Respir Rev. 2021;30(159):200346.","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10370_CR47","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/jcm8050726","volume":"8","author":"EA Yang","year":"2019","unstructured":"Yang EA, Kang HM, Rhim JW, Kang JH, Lee KY. Early corticosteroid therapy for Mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children. J Clin Med. 2019;8(5):726.","journal-title":"J Clin Med"},{"issue":"1","key":"10370_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12890-019-0990-8","volume":"19","author":"HS Kim","year":"2019","unstructured":"Kim HS, Sol IS, Li D, Choi M, Choi YJ, Lee KS, Seo JH, Lee YJ, Yang HJ, Kim HH. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19(1):251.","journal-title":"BMC Pulm Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10370-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T10:03:01Z","timestamp":1735898581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10370-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10370"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10370-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committees of Affiliated Hospital of Jiangsu University and Affiliated Hospital of Xuzhou Medical University, respectively. The informed consents of patients were waived by both Research Ethics Committees due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}